Search Results - "SPACZYNSKI, Marek"

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years by Schwarz, Tino F, Spaczynski, Marek, Schneider, Achim, Wysocki, Jacek, Galaj, Andrzej, Perona, Pamela, Poncelet, Sylviane, Zahaf, Toufik, Hardt, Karin, Descamps, Dominique, Dubin, Gary

“…Abstract The immunogenicity and safety of an HPV-16/18 AS04-adjuvanted vaccine were assessed in women aged 26–55 years and compared with women aged 15–25 years…”
Get full text

Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy by Magnowska, Magdalena, Iżycka, Natalia, Kapoła-Czyż, Joanna, Romała, Anna, Lorek, Jakub, Spaczyński, Marek, Nowak-Markwitz, Ewa

“…Chemotherapy-induced peripheral neuropathy (CIPN) is a common chemotherapy side effect, but its prevention and treatment remains a challenge. Neurotoxicity may…”
Get full text

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age by Schwarz, Tino F., Galaj, Andrzej, Spaczynski, Marek, Wysocki, Jacek, Kaufmann, Andreas M., Poncelet, Sylviane, Suryakiran, Pemmaraju V., Folschweiller, Nicolas, Thomas, Florence, Lin, Lan, Struyf, Frank

“…Women remain at risk of human papillomavirus (HPV) infection for most of their lives. The duration of protection against HPV‐16/18 from prophylactic…”
Get full text

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy by Nowak-Markwitz, Ewa, M.D., Ph.D, Michalak, Marcin, M.D., Ph.D, Olejnik, Mikołaj, M.D., Ph.D, Spaczynski, Marek, M.D., Ph.D

“…Objective To assign cutoff values for human chorionic gonadotropin (β-hCG) in pretreatment and after one methotrexate (MTX) cycle and determine its…”
Get full text

ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome by SUROWIAK, Pawel, MATERNA, Verena, KAPLENKO, Irina, SPACZYNSKI, Marek, DOLINSKA-KRAJEWSKA, Barbara, GEBAROWSKA, Elzbieta, DIETEL, Manfred, ZABEL, Maciej, LAGE, Hermann

“…Purpose: Cisplatin resistance is a major obstacle in the treatment of ovarian carcinoma. ABCC2 is commonly localized in apical cell membranes and could confer…”
Get full text

Expression of the MT1 melatonin receptor in ovarian cancer cells by Jablonska, Karolina, Pula, Bartosz, Zemla, Agata, Kobierzycki, Christopher, Kedzia, Witold, Nowak-Markwitz, Ewa, Spaczynski, Marek, Zabel, Maciej, Podhorska-Okolow, Marzenna, Dziegiel, Piotr

“…Ovarian cancer (OC) is the leading cause of death among women with genital tract disorders. Melatonin exhibits oncostatic properties which it may effect…”
Get full text

Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients by Hałoń, Agnieszka, Nowak-Markwitz, Ewa, Donizy, Piotr, Matkowski, Rafał, Maciejczyk, Adam, Gansukh, Tserenchunt, Györffy, Balázs, Spaczyński, Marek, Zabel, Maciej, Lage, Hermann, Surowiak, Paweł

“…Degradation of the extracellular matrix and basement membrane is a critical step in tumor progression. Matrix metalloproteinase 2 (MMP-2) and tissue inhibitor…”
Get full text

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome by SUROWIAK, Pawel, MATERNA, Verena, MACIEJCZYK, Adam, PUDELKO, Marek, MARKWITZ, Ewa, SPACZYNSKI, Marek, DIETEL, Manfred, ZABEL, Maciej, LAGE, Hermann

“…Elevated metallothionein (MT) expression in ovarian cancers treated with cisplatin-based schemes represents an unfavorable prognostic index. MT expression is…”
Get full text

Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis by Gąsiorowska, Emilia, Michalak, Marcin, Warchoł, Wojciech, Lemańska, Agnieszka, Jasiński, Piotr, Spaczyński, Marek, Nowak-Markwitz, Ewa

“…The aim of this study was to assess the sensitivity and specificity of HE4 in detecting and differentiating between types I and II epithelial ovarian cancer…”
Get full text

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials by Gabrail, Nashat, Yanagihara, Ronald, Spaczyński, Marek, Cooper, William, O'Boyle, Erin, Smith, Carrie, Boccia, Ralph

“…Despite advances with new therapies, a significant proportion of patients (>30%) suffer delayed-onset chemotherapy-induced nausea and vomiting (CINV) despite…”
Get full text

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population by Mędrek, Krzysztof, Magnowski, Piotr, Masojć, Bartłomiej, Chudecka-Głaz, Anita, Torbe, Bogdan, Menkiszak, Janusz, Spaczyński, Marek, Gronwald, Jacek, Lubiński, Jan, Górski, Bohdan

“…Among many alterations within the TP53 gene the rs1042522 (C72G, p.Pro72Arg) has been associated with numerous cancers , however the results differ between…”
Get full text

Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years by Schwarz, Tino F., Spaczynski, Marek, Schneider, Achim, Wysocki, Jacek, Galaj, Andrzej, Schulze, Karin, Poncelet, Sylviane M., Catteau, Gregory, Thomas, Florence, Descamps, Dominique

“…The HPV-16/18 AS04-adjuvanted vaccine (Cervarix®, GlaxoSmithKline Biologicals) has been shown to induce a robust immune response in women aged 15-55 years…”
Get full text

Human papilloma virus genotyping in women with CIN 1 by Kedzia, Witold, Józefiak, Agata, Pruski, Dominik, Rokita, Wojciech, Marek, Spaczyński

“…Cervical cancer remains a considerable diagnostic and therapeutic problem in Poland. Despite progress in creating an active cancer prevention program in our…”
Get full text

CD46 Expression is Indicative of Shorter Revival-free Survival for Ovarian Cancer Patients by SUROWIAK, Pawel, MATERNA, Verena, MACIEJCZYK, Adam, KAPLENKO, Irina, SPACZYNSKI, Marek, DIETEL, Manfred, LAGE, Hermann, ZABEL, Maciej

“…Background: The membrane cofactor protein CD46 represents a complement inhibitor, which protects autologous cells from complement - mediated cytotoxicity. CD46…”
Get full text

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine by Schwarz, Tino F., Kocken, Mariëlle, Petäjä, Tiina, Einstein, Mark H., Spaczynski, Marek, Louwers, Jacqueline A., Pedersen, Court, Levin, Myron, Zahaf, Toufik, Poncelet, Sylviane, Hardt, Karin, Descamps, Dominique, Dubin, Gary

“…This pooled analysis of data from four Phase III clinical trials was undertaken to assess the correlation between levels of anti-human papillomavirus…”
Get full text

Recommendations of the Polish Gynecological Society concerning application of progesterone in obstetrics and gynecology by Bomba-Opoń, Dorota, Czajkowski, Krzysztof, Karowicz-Bilińska, Agata, Kotarski, Jan, Nowak-Markwitz, Ewa, Oszukowski, Przemysław, Paszkowski, Tomasz, Poreba, Ryszard, Spaczyński, Marek, Wielgoś, Mirosław

Get full text

Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients by MATERNA, Verena, SUROWIAK, Pawel, KAPLENKO, Irina, SPACZYNSKI, Marek, ZHENFENG DUAN, ZABEL, Maciej, DIETEL, Manfred, LAGE, Hermann

“…An obstacle in chemotherapy of ovarian cancer is the development of drug resistance. Taxol (paclitaxel)-resistance-associated gene-3 (TRAG-3/CSAG2) was found…”
Get full text

Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009 by Spaczyński, Marek, Karowicz-Bilinska, Agata, Rokita, Wojciech, Molińska-Glura, Marta, Januszek-Michalecka, Lucyna, Seroczyński, Przemysław, Uchlik, Joanna, Nowak-Markwitz, Ewa

“…In Poland in 2007, according to the National Cancer Registry 3431 women were diagnosed with cervical cancer and 1907 died. To change the unfavorable…”
Get full text

Current status of human papillomavirus vaccination implementation in central and eastern Europe by Seme, Katja, Maver, Polona J, Korać, Tina, Canton, Amalia, Částková, Jitka, Dimitrov, Goran, Filippova, Irina, Hudecová, Helena, Iljazović, Ermina, Kaić, Bernard, Kesić, Vesna, Kuprevičienė, Nerija, Laušević, Dragan, Molnár, Zsuzsanna, Perevoščikovs, Jurijs, Spaczyński, Marek, Stefanova, Venera, Učakar, Veronika, Poljak, Mario

“…We present a review of the current implementation status of vaccination against human papillomaviruses (HPV) and available data concerning the burden of HPV…”
Get full text

Assessment of frequency of regression and progression of mild cervical neoplasia--LGSIL in women with positive high-risk HPV DNA test result by Pruski, Dominik, Fraszczak, Joanna, Iwaniec, Kinga, Przybylski, Marcin, Kedzia, Witold, Gretkiewicz-Tomczyk, Anna, Karowicz-Bilińska, Agata, Spaczyński, Marek

“…Assessment of frequency of regression and progression of mild cervical neoplasia in women positive for types of HPV DNA of high oncogenic potential. 111 women…”
Get full text